Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), China Pharmaceutical University, Nanjing 210009, PR China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, PR China.
J Chromatogr A. 2021 Jan 25;1637:461866. doi: 10.1016/j.chroma.2020.461866. Epub 2020 Dec 31.
New material zeolitic imidazolate framework-4, 5-imidazoledicarboxylic acid (ZIF-IMD) located on the pore surface of porous layer open-tubular (PLOT) column previously functionalized with N-(3-aminopropyl)-imidazole have been prepared via a layer-by-layer self-assembly strategy. This new ZIF-IMD coating hybrids are used as solid-phase carriers for chiral selector pepsin immobilization. The ZIF-IMD material was characterized by scanning electron microscopy, energy-dispersive spectroscopy, transmission electron microscope and X-ray diffraction. The synthesized pepsin@ZIF-IMD@POLT column achieved the baseline separation of hydroxychloroquine (HCQ), chloroquine (CHQ) and hydroxyzine (HXY) (the resolution of HCQ: 2.19; CHQ: 1.84; HXY: 1.53). Compared with the pepsin@PLOT column (without ZIF-IMD material), the chiral separation capability of the pepsin@ZIF-IMD@POLT column can be remarkably improved. Several key parameters including concentration of chiral selector, buffer pH, applied voltage and buffer concentration were systematically evaluated to provide the optimal enantioseparation condition. The relative standard deviations (RSDs) of intra-day, inter-day, column-to-column and inter-batch of migration time and Rs of the HCQ were evaluated in detail, respectively (RSD < 7.21%). Additionally, the potential mechanism of increased resolution was discussed in the article.
先前用 N-(3-氨基丙基)-咪唑功能化的多孔层开口管 (PLOT) 柱的孔表面上制备了新型沸石咪唑酯骨架-4、5-咪唑二羧酸 (ZIF-IMD)。这种新的 ZIF-IMD 涂层杂化体被用作手性选择剂胃蛋白酶固定化的固相载体。通过扫描电子显微镜、能量色散光谱、透射电子显微镜和 X 射线衍射对 ZIF-IMD 材料进行了表征。合成的胃蛋白酶@ZIF-IMD@POLT 柱实现了羟氯喹 (HCQ)、氯喹 (CHQ) 和羟嗪 (HXY) 的基线分离 (HCQ 的分辨率:2.19;CHQ:1.84;HXY:1.53)。与胃蛋白酶@PLOT 柱(不含 ZIF-IMD 材料)相比,胃蛋白酶@ZIF-IMD@POLT 柱的手性分离能力可以得到显著提高。系统评估了几个关键参数,包括手性选择剂的浓度、缓冲液 pH 值、施加电压和缓冲液浓度,以提供最佳的对映体分离条件。详细评估了 HCQ 的迁移时间和 Rs 的日内、日间、柱间和批间相对标准偏差 (RSD)(RSD<7.21%)。此外,本文还讨论了分辨率提高的潜在机制。